Article
MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 May 2007
Zhou Gangqiao, Zhai Yun, Cui Ying, Zhang Xiumei, Dong Xiaojia, Yang Hao, He Ying, Yao Kaitai, Zhang Hongxing, Zhi Lianteng, Yuan Xiaoyan, Qiu Wei, Zhang Xiaoai, Shen Yan, Qiang Boqing, He Fuchu
Abstract excerpt
PURPOSE: Mouse double minute 2 (MDM2) is a key negative regulator of the p53 activity. Recently, a polymorphism in the MDM2 intronic promoter, SNP309, was shown to influence MDM2 expression and p53 activity. We examined whether the SNP309 was related to the risk of developing nasopharyngeal carcinoma (NPC) among Chinese populations. EXPERIMENTAL DESIGN: We genotyped the SNP309 in two independent case-control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
